ENTO
Entero Therapeutics
ENTO
ENTO
10 hedge funds and large institutions have $4.25M invested in Entero Therapeutics in 2021 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
less ownership
Funds ownership: →
Holders
10
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$640K | |
| 2 | +$350K | |
| 3 | +$343K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$209K |
| 5 |
EDRH
Edmond de Rothschild Holding
Chambesy,
Switzerland
|
+$134K |
Top Sellers
| 1 | -$181K | |
| 2 | -$54K | |
| 3 | -$49K | |
| 4 |
BPA
Beacon Pointe Advisors
Newport Beach,
California
|
-$38K |
| 5 |
TCM
Traynor Capital Management
Malvern,
Pennsylvania
|
-$31K |